1-20 of 370
Michael Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

Open Access
Wei Wang, Qingsong Cai, Yang Liu, Lei Nie, Heng-Huan Lee, Fangfang Yan, Yue Fei, Yixin Yao, Yijing Li, Lin Tan, Philip L. Lorenzi, Ying-Nai Wang, Jun Yao, Zhihong Chen, Joseph Mitchell McIntosh, Cheng-Tai Yu, Preetesh Jain, Vivian C. Jiang, Jovanny Vargas, Xiaolin Li, Tianci Zhang, Shaoying Li, David Santos, Selvi Thirumurthi, Erin Heather Seeley, Lukas Mikolaj Simon, Christopher Flowers, Chi Young Ok, Michael Wang
Journal: Blood
Blood (2025) 146 (21): 2544–2560.
https://doi.org/10.1182/blood.2024026919
Published: 2025
Includes: Supplemental data
Journal Articles

Association of CAR T cell kinetics with outcomes after standard of care brexucabtagene autoleucel for relapsed/refractory Mantle Cell Lymphoma

Free
Anath Lionel, Susan Wu, Ahmed Fetooh, Penny Fang, Rita Khouri, Jason Westin, Christopher Flowers, Timothy Lin, Chelsea Pinnix, Bouthaina Dabaja, Jillian Gunther, Jeremy Ramdial, Samer Srour, Elizabeth Shpall, Partow Kebriaei, Sa Wang, Sattva Neelapu, Sairah Ahmed, Michael Wang, Preetesh Jain
Journal: Blood
Blood (2025) 146 (Supplement 1): 7092.
https://doi.org/10.1182/blood-2025-7092
Published: 2025
Journal Articles

Enhancing the expansion of Naïve, potent T-cells via BTK inhibition reinvigorates CD19-CAR T-cell immunity and boosts antitumor efficacy in relapsed Mantle Cell Lymphoma

Free
Yixin Yao, Yue Fei, Xiaolin Li, Joseph McIntosh, Yang Liu, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1785.
https://doi.org/10.1182/blood-2025-1785
Published: 2025
Journal Articles

Acalabrutinib plus rituximab followed by brexucabtagene autoleucel for frontline treatment of high-risk Mantle Cell Lymphoma: The window-3 clinical trial

Free
Preetesh Jain, Sairah Ahmed, Chi Young Ok, Ranjit Nair, Ahmed Fetooh, Holly Hill, Tatiana Vasilyeva, Ajlan Al Zaki, Anastasiya Evdokimova, Viktor Smirnov, Tolina Turova, Ilya Anosov, Lizzie Sheehan, Selvi Thirumurthi, Anita Deswal, Cezar Iliescu, Vinh Nguyen, Joel Thomas, Naveen Garg, Dhruv Kumar, Cameron Noorbakhsh, Sa Wang, Keyur Patel, Francisco Vega, L. Jeffrey Medeiros, Guilin Tang, Partow Kebriaei, Neeraj Saini, Susan Wu, Bouthaina Dabaja, Nikkita Kotlov, Michael Goldberg, Cara Haymaker, Christopher Flowers, Sattva Neelapu, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 666.
https://doi.org/10.1182/blood-2025-666
Published: 2025
Journal Articles

Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study

Free
Michael Wang, Jonathon Cohen, Nirav Shah, Wojciech Jurczak, Pier Luigi Zinzani, Chan Cheah, Chaitra Ujjani, Youngil Koh, Won Seog Kim, Sunita Dwivedy Nasta, Ian Flinn, Benoit Tessoulin, Shuo Ma, Alvaro Alencar, David Lewis, Jennifer Woyach, Kami Maddocks, Krish Patel, Yucai Wang, Joanna Rhodes, Constantine Tam, John Seymour, Hirokazu Nagai, Julie Vose, Bita Fakhri, Marc Hoffmann, Francisco Hernandez-Ilizaliturri, Andrew Zelenetz, Anita Kumar, Talha Munir, Donald Tsai, Paolo Abada, Minna Balbas, Jian Li, Ying (denise) Wang, Lindsey Roeker, Toby Eyre
Journal: Blood
Blood (2025) 146 (Supplement 1): 665.
https://doi.org/10.1182/blood-2025-665
Published: 2025
Journal Articles

Sonrotoclax (BGB-11417) monotherapy in patients with Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL) previously treated with a bruton tyrosine kinase (BTK) inhibitor: Early results from A phase 1/2 study

Free
Michael Wang, Yuqin Song, Olivier Hermine, Yuerong Shuang, Wojciech Jurczak, João Samuel de Holanda Farias, Carolina Mahuad, Muhit Ozcan, Ron D. Jachimowicz, Tianlei Chen, Elena Ivanova, Xiaotong Li, Gabriel Man, Priscille Bourquelot, Remus Vezan, Toby Eyre
Journal: Blood
Blood (2025) 146 (Supplement 1): 663.
https://doi.org/10.1182/blood-2025-663
Published: 2025
Journal Articles

Time to third-line treatment after bendamustine-rituximab with or without acalabrutinib in patients with previously untreated mantle cell lymphoma: Updated analysis of the phase 3 ECHO trial after 50 months of follow-up

Free
Michael Wang, Jonas Paludo, João Samuel de Holanda Farias, Diego Villa, Cecily Forsyth, Ellie John, Menglu Che, Harneet Arora, Craig Delury, Victoria Otero, Yuqin Song
Journal: Blood
Blood (2025) 146 (Supplement 1): 885.
https://doi.org/10.1182/blood-2025-885
Published: 2025
Journal Articles

Acalabrutinib plus venetoclax and rituximab in patients with treatment-naive (TN) mantle cell lymphoma (MCL): Results from the Phase 2 TrAVeRse study

Free
Eliza Hawkes, Joanna Romejko-Jarosinska, Wojciech Jurczak, Sunil Iyengar, Abel Costa, Nimish Shah, Monique Menzies Wojtowicz, Allison Winter, Adam Witkowski, Neil Chua, Ana Jiménez Ubieto, John Kuruvilla, Diego Villa, Chan Cheah, Andre Goy, Elise Chong, Andrew Wood, Rachel Fletcher, Stefanie Meyer, Rebecca Silva, Simon Rule, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 884.
https://doi.org/10.1182/blood-2025-884
Published: 2025
Journal Articles

Interim PET-adapted de-escalation chemotherapy regimen for advanced stage classical Hodgkin lymphoma using brentuximab vedotin, pembrolizumab, doxorubicin, and dacarbazine: Phase 2 study

Free
Hun Lee, Gregory Ravizzini, Jenna Wixom, Ayushi Chauhan, Luis Fayad, Ranjit Nair, Jason Westin, Jared Henderson, Eslam Aboismail, Christopher Flowers, Michael Wang, Luis Malpica Castillo
Journal: Blood
Blood (2025) 146 (Supplement 1): 153.
https://doi.org/10.1182/blood-2025-153
Published: 2025
Journal Articles

Pirtobrutinib in Relapsed/Refractory (R/R) Waldenström macroglobulinemia (WM): Up to 5 years of follow-up from the Phase 1/2 BRUIN study

Free
Chan Cheah, Manish Patel, Toby Eyre, Wojciech Jurczak, David Lewis, Thomas Gastinne, Shuo Ma, Jonathon Cohen, Krish Patel, Jennifer Brown, Lydia Scarfo, Talha Munir, Ewa Lech-Maranda, Marc Hoffmann, Chaitra Ujjani, Bita Fakhri, Michael Wang, Koji Izutsu, Hirokazu Nagai, Constantine Tam, Joanna Rhodes, Julie Vose, Matthew McKinney, James Gerson, Minal Barve, Bryone Kuss, Youngil Koh, Aisling Barrett, Steven Treon, Jorge Castillo, John Seymour, Amy Ruppert Stark, Samuel McNeely, Richard Walgren, Donald Tsai, Katherine Bao, Binoj Chandrasekharan Nair, Jennifer Woyach, Lia Palomba
Journal: Blood
Blood (2025) 146 (Supplement 1): 226.
https://doi.org/10.1182/blood-2025-226
Published: 2025
Journal Articles

Multi-center real world analysis of treatment outcomes of non-COVALENT btki, pirtobrutinib, in patients with COVALENT btki relapsed/refracdtory Mantle Cell Lymphoma

Free
Paolo Lopedote, Adrienne Nedved, Lu Chen, Marcus Watkins, Arian Roua, Muhamad Alhaj Moustafa, Seyi Abidoye, Yun Choi, Georgios Pongas, Tony Zhuang, Jean Clement, Megan Searssmith, Laura Sun, Hannah Willis, Brad Kahl, David Bond, Javier Munoz, Izidore S. Lossos, Craig Portell, Michael Wang, Nilanjan Ghosh, Jonathon Cohen, Peter Martin, Jeremy Abramson, Anne Beaven, Patrick Reagan, Daniel Ermann, Taylor Brooks, Ashlee Joseph, Nazila Shafagati, Daniel McLoughlin, Kira Rosenlind, Brian Hill, Nina Wagner-Johnston, Anita Kumar, Umar Farooq, Reem Karmali, Tanaya Shree, Matthew Lunning, Stacy Pak, Alexey Danilov, Yucai Wang, Tycel Phillips
Journal: Blood
Blood (2025) 146 (Supplement 1): 5351.
https://doi.org/10.1182/blood-2025-5351
Published: 2025
Journal Articles

Dissecting pirtobrutinib resistance in Mantle Cell Lymphoma through single-cell multi-omics

Free
Fangfang Yan, Yang Liu, Heng-Huan Lee, Wei Wang, Joseph McIntosh, Yijing Li, Jovanny Vargas, Yue Fei, Lukas Simon, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1765.
https://doi.org/10.1182/blood-2025-1765
Published: 2025
Journal Articles

Artificial intelligence predicts genetic network disruptions to overcome CAR-T resistance in Mantle Cell Lymphoma

Free
Fangfang Yan, Yang Liu, Heng-Huan Lee, Han Liang, Lukas Simon, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1764.
https://doi.org/10.1182/blood-2025-1764
Published: 2025
Journal Articles

Durable responses in the updated 2-year follow-up of patients from a single-center with Relapsed/Refractory peripheral T-cell lymphoma treated with golidocitinib

Free
Eduardo Edelman Saul, Jessie Xu, Casey Bermack, Cathrine Paras, Jared Henderson, Kristofer Jennings, Bryan Valcarcel, Dr. Mohammad Abdul-Jaber Abdulla, Luis Fayad, Hun Lee, Preetesh Jain, Ranjit Nair, Michael Wang, Swami Iyer, Christopher Flowers, Luis Malpica
Journal: Blood
Blood (2025) 146 (Supplement 1): 5422.
https://doi.org/10.1182/blood-2025-5422
Published: 2025
Journal Articles

Two-year update of ZUMA-2 Cohort 3: Brexucabtagene autoleucel (Brexu-cel) in patients (pts) with relapsed/refractory mantle cell lymphoma (R/R MCL) who had not received prior Bruton tyrosine kinase inhibitor (BTKi) therapy

Free
Tom Van Meerten, Marie José Kersten, Gloria Iacoboni, Georg Hess, Pim Mutsaers, Alejandro Martin Garcia-Sancho, Andre Goy, Eva Gine, Brian Hill, Wen-Kai Weng, Martin Dreyling, Patrick Reagan, Krish Patel, Ahmed Galal, Charles Herbaux, Robin Sanderson, Dan Zheng, Sabina Adhikary, Wangshu Zhang, Rita Damico Khalid, Ioana Kloos, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 1799.
https://doi.org/10.1182/blood-2025-1799
Published: 2025
Journal Articles

Impact of extranodal sites of lymphoma on clinical outcomes after CD19 CAR T cell therapy

Free
Anath Lionel, Sushanth Gouni, Karan Chohan, Lei Feng, Charles Gaulin, Amrit Gonugunta, Victoria Chu, Zachary Hunzeker, James Hill, Turcin Saridogan, Michelly Abreu, Jaimole Varghese, Karla Ow, Minifrida Santiago, Amy Ayers, Farzaneh Maadani, Maria Guillermo-Pacheco, Janet Torres, Sherry Adkins, Misha Hawkins, Mark Hamilton, Fateeha Furqan, Ayushi Chauhan, Ranjit Nair, Chijioke Nze, Hun Lee, Preetesh Jain, Luis Malpica, Luis Fayad, Michael Wang, Dai Chihara, Swami Iyer, Chitra Hosing, Jeremy Ramdial, Partow Kebriaei, Elizabeth Shpall, Jason Westin, Christopher Flowers, Susan Wu, Paolo Strati, Sattva Neelapu, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 1931.
https://doi.org/10.1182/blood-2025-1931
Published: 2025
Journal Articles

Phase II Trial of lenalidomide plus rituximab (R2) in previously untreated follicular lymphoma: 15-year follow up data from MDACC Trial

Free
Dai Chihara, Paolo Strati, Preetesh Jain, Luis Fayad, Frederick Hagemeister, Maria Rodriguez, Richard Davis, Michael Wang, Sattva Neelapu, Christopher Flowers, Jason Westin
Journal: Blood
Blood (2025) 146 (Supplement 1): 5369.
https://doi.org/10.1182/blood-2025-5369
Published: 2025
Journal Articles

The switch of TCA cycle mode determines the fate of pirtobrutinib-tolerant persister cells

Free
Michael Wang, Yang Liu, Qingsong Cai, Lei Nie, Heng-Huan Lee, Fangfang Yan, Yue Fei, Yijing Li, Lin Tan, Philip Lorenzi, Cheng-Tai Yu, Wei Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 330.
https://doi.org/10.1182/blood-2025-330
Published: 2025
Journal Articles

Germline variants and their role in the pathogenesis of immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome (IEC-HS) in adult lymphoma patients

Free
Anath Lionel, Cuong Le, Jianlong Liao, Sushanth Gouni, Xubin Li, Faezeh Darbaniyan, Jared Henderson, Ajlan Al Zaki, Federico Mario Aletti, Christen Dillard, Krina Patel, Amy Ayers, Misha Hawkins, Frederick Hagemeister, Maria Rodriguez, Hun Lee, Luis Fayad, Ranjit Nair, Luis Malpica, Chijioke Nze, Preetesh Jain, Michael Wang, Elizabeth Shpall, Partow Kebriaei, Swami Iyer, Dai Chihara, Paolo Strati, Jason Westin, Christopher Flowers, Sairah Ahmed, Linghua Wang, Michael R Green, Sattva Neelapu
Journal: Blood
Blood (2025) 146 (Supplement 1): 806.
https://doi.org/10.1182/blood-2025-806
Published: 2025
Journal Articles

First-in-class dual BTK-MALT1 fusion inhibitors for treating resistant Mantle Cell Lymphoma

Free
Vivian Jiang, Mingxiang Zhou, Hong Kim, Lei Nie, Qingsong Cai, Tianci Zhang, Chengtai Yu, Joseph McIntosh, Jun Yao, Jovanny Vargas, Yang Liu, Haiying Chen, Jia Zhou, Michael Wang
Journal: Blood
Blood (2025) 146 (Supplement 1): 390.
https://doi.org/10.1182/blood-2025-390
Published: 2025